PD03-07 TESTING THE EXTERNAL VALIDITY OF CARMENA TRIAL COMPARING SUNITINIB ALONE OR AFTER NEPHRECTOMY IN METASTATIC RENAL-CELL CARCINOMA

Authors :: Amit R. Patel
Firas Abdollah
Mani Menon
Audrey Fotouhi
Jacob Keeley
Sohrab Arora
Akshay Sood
Ulyana Prokopiv
Deepansh Dalela
Nikola Rakic
Craig G. Rogers
Quoc-Dien Trinh
Source :: Journal of Urology. 201
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.
Abstract: INTRODUCTION AND OBJECTIVES:The CARMENA phase III randomized trial reported that overall survival with sunitinib alone is noninferior to the combination of nephrectomy followed by sunitinib in pati...

Subjects :: medicine.medical_specialty
business.industry
Sunitinib
Urology
medicine.medical_treatment
medicine.disease
Nephrectomy
law.invention
External validity
Randomized controlled trial
law
Renal cell carcinoma
Overall survival
Medicine
business
medicine.drug

Full Text Access

Tools